Aaron Levie, Alexis Ohanian, R.J. Halperin, Cristóbal Valenzuela, David Zagaynov, Sam Lessin, xAI Merges with X, Isomorphic Labs Raises $600M
TBPN Live
Google's Venture Studio Model and AI in Drug Development
This chapter explores Google's strategic approach to external investments, comparing it to a venture studio model that drives growth through accountability. It delves into the complexities of startup equity structures, highlighting the impact of funding rounds and the significant advancements in AI-driven drug design, particularly through DeepMind's AlphaFold. The conversation critiques conventional communication in the life sciences sector and emphasizes the need for innovation in medical AI, focusing on collaborations with pharmaceutical giants and the aspirations to revolutionize drug development.
00:00
Transcript
Play full episode
Remember Everything You Learn from Podcasts
Save insights instantly, chat with episodes, and build lasting knowledge - all powered by AI.
